Palcigen 125 mg (Capsule)
Unit Price: ৳ 400.00 (1 x 21: ৳ 8,400.00)
Strip Price: ৳ 8,400.00
Medicine Details
Category | Details |
---|---|
Generic | Palbociclib |
Company | General pharmaceuticals ltd |
Indications
- Treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer
Dosage & Administration
- Oral administration
- 125 mg capsule
- Once daily for 21 consecutive days followed by 7 days off treatment
Mode of Action
- Inhibitor of Cyclin-dependent kinases (CDK) 4 and 6
- Blocks progression of the cell cycle
- Reduces cellular proliferation of Estrogen receptor (ER)-positive breast cancer cell lines
Interaction
- Metabolized by CYP3A and Sulfotransferase (SULT) enzyme SULT2A1
- Time-dependent inhibitor of CYP3A
- Effects of CYP3A-Inhibitors and CYP3A Inducers on plasma concentrations
- Alters plasma concentrations of other drugs
Side Effects
- Decreased WBC, Neutrophils, and Platelets
- Infections
- Increased AST and ALT
- Hair loss
- Nausea
- Anemia
- Rash
- Weakness/lethargy
- Vomiting
- Dry skin
- Fever
Pregnancy & Lactation
- Can cause fetal harm
- Risk of major birth defects and miscarriage
Precautions & Warnings
- Neutropenia
- Interstitial Lung Disease (ILD)/Pneumonitis
- Embryo Fetal Toxicity
- Dose modifications for adverse reactions
Overdose Effects
- No known antidote
- General supportive measures for overdose
Therapeutic Class
- Protein kinase inhibitor
Storage Conditions
- Keep below 30°C temperature
- Away from light and moisture
- Keep out of the reach of children